Cargando…

Randomized phase 2 study of adjunctive cenobamate in patients with uncontrolled focal seizures

OBJECTIVE: To evaluate the efficacy and safety of adjunctive cenobamate 200 mg/d in patients with uncontrolled focal (partial-onset) seizures despite treatment with 1 to 3 antiepileptic drugs. METHODS: In this multicenter, double-blind, placebo-controlled study, adults 18 to 65 years of age with foc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chung, Steve S., French, Jacqueline A., Kowalski, Jacek, Krauss, Gregory L., Lee, Sang Kun, Maciejowski, Maciej, Rosenfeld, William E., Sperling, Michael R., Mizne, Sarah, Kamin, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357293/ https://www.ncbi.nlm.nih.gov/pubmed/32409485 http://dx.doi.org/10.1212/WNL.0000000000009530

Ejemplares similares

Long‐term safety of adjunctive cenobamate in patients with uncontrolled focal seizures: Open‐label extension of a randomized clinical study
por: French, Jacqueline A., et al.
Publicado: (2021)

Long-term Efficacy and Safety From an Open-Label Extension of Adjunctive Cenobamate in Patients With Uncontrolled Focal Seizures
por: Klein, Pavel, et al.
Publicado: (2022)

Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open‐label safety study
por: Sperling, Michael R., et al.
Publicado: (2020)

Efficacy of cenobamate for uncontrolled focal seizures: Post hoc analysis of a Phase 3, multicenter, open‐label study
por: Sperling, Michael R., et al.
Publicado: (2021)

Critical Appraisal of Cenobamate as Adjunctive Treatment of Focal Seizures in Adults
por: Zaccara, Gaetano, et al.
Publicado: (2021)

Post hoc analysis of a phase 3, multicenter, open‐label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant antiseizure medications
por: Rosenfeld, William E., et al.
Publicado: (2021)

Effectiveness and safety of adjunctive cenobamate for focal seizures in adults with developmental disability treated in clinical practice
por: Connor, Gregory S., et al.
Publicado: (2022)

Suppression of the photoparoxysmal response in photosensitive epilepsy with cenobamate (YKP3089)
por: Kasteleijn- Nolst Trenite, Dorothee G.A., et al.
Publicado: (2019)

Adjunctive Cenobamate for Focal-Onset Seizures in Adults: A Systematic Review and Meta-Analysis
por: Lattanzi, Simona, et al.
Publicado: (2020)

Cenobamate for treatment-resistant focal seizures: current evidence and place in therapy
por: Singh, Alok
Publicado: (2022)

Long‐term individual retention with cenobamate in adults with focal seizures: Pooled data from the clinical development program
por: Sander, Josemir W., et al.
Publicado: (2021)

Real‐world safety and effectiveness of cenobamate in patients with focal onset seizures: Outcomes from an Expanded Access Program
por: Villanueva, Vicente, et al.
Publicado: (2023)

Cost-effectiveness of perampanel as an adjunctive treatment for uncontrolled focal seizures in pediatric patients: a Chinese perspective
por: Hu, Yani, et al.
Publicado: (2022)

Adjunctive pregabalin vs gabapentin for focal seizures: Interpretation of comparative outcomes
por: French, Jacqueline, et al.
Publicado: (2016)

Remarkably High Efficacy of Cenobamate in Adults With Focal-Onset Seizures: A Double-Blind, Randomized, Placebo-Controlled Trial
por: Vossler, David G.
Publicado: (2020)

Anticonvulsant effects of cenobamate in chemically and electrically induced seizure models in rodents
por: Melnick, Susan M., et al.
Publicado: (2023)

Dose Adjustment of Concomitant Antiseizure Medications During Cenobamate Treatment: Expert Opinion Consensus Recommendations
por: Smith, Michael C., et al.
Publicado: (2022)

Clinical utility of implantable neurostimulation devices as adjunctive treatment of uncontrolled seizures
por: Cox, Joanna H, et al.
Publicado: (2014)

Sustained seizure freedom with adjunctive brivaracetam in patients with focal onset seizures
por: Lattanzi, Simona, et al.
Publicado: (2022)

Onset of efficacy and adverse events during Cenobamate titration period
por: Steinhoff, Bernhard J., et al.
Publicado: (2022)

Sensitivity and responsiveness of the EQ-5D-3L in patients with uncontrolled focal seizures: an analysis of Phase III trials of adjunctive brivaracetam
por: Mukuria, Clara, et al.
Publicado: (2016)

Efficacy and tolerability of adjunctive lacosamide in pediatric patients with focal seizures
por: Farkas, Viktor, et al.
Publicado: (2019)

Is Cenobamate the Breakthrough We Have Been Wishing for?
por: Specchio, Nicola, et al.
Publicado: (2021)

Cenobamate significantly improves seizure control in intellectually disabled patients with drug-resistant epilepsy and allows drug load reduction
por: Friedo, Anna-Lena, et al.
Publicado: (2023)

Economic Value of Adjunctive Brivaracetam Treatment Strategy for Focal Onset Seizures in Finland
por: Väätäinen, Saku, et al.
Publicado: (2019)

Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial-onset seizures: Results of a phase III, double-blind, randomized, placebo-controlled trial
por: Sperling, Michael R, et al.
Publicado: (2015)

New evidence in adjunctive treatment of focal-onset seizures in adults: a critical appraisal
por: Lattanzi, Simona
Publicado: (2022)

An Ex Vivo Evaluation of Cenobamate Administered via Enteral Tubes
por: Ferrari, Louis, et al.
Publicado: (2020)

Real-World Experience Treating Pediatric Epilepsy Patients With Cenobamate
por: Makridis, Konstantin L., et al.
Publicado: (2022)

Cenobamate in refractory epilepsy: Overview of treatment options and practical considerations
por: Schmitz, Bettina, et al.
Publicado: (2023)

Effect of cenobamate on the single‐dose pharmacokinetics of multiple cytochrome P450 probes using a cocktail approach in healthy subjects
por: Greene, Stephen A., et al.
Publicado: (2021)

Efficacy and tolerability of lacosamide as adjunctive therapy in patients with focal-onset seizures: an observational, prospective study
por: Jin, Yang, et al.
Publicado: (2023)

Seizure Susceptibility Prediction in Uncontrolled Epilepsy
por: Truong, Nhan Duy, et al.
Publicado: (2021)

Cenobamate (YKP3089) and Drug-Resistant Epilepsy: A Review of the Literature
por: Rissardo, Jamir Pitton, et al.
Publicado: (2023)

Adjunctive Transdermal Cannabidiol for Adults With Focal Epilepsy: A Randomized Clinical Trial
por: O’Brien, Terence J., et al.
Publicado: (2022)

Safety, Tolerability and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy in Patients Aged ≥ 65 Years with Focal Seizures
por: Costa, Raquel, et al.
Publicado: (2018)

Safety and Tolerability of Adjunctive Eslicarbazepine Acetate in Pediatric Patients (Aged 4-17 Years) With Focal Seizures
por: Mintz, Mark, et al.
Publicado: (2019)

Efficacy and Tolerability of Perampanel as Adjunctive Therapy in Chinese Patients With Focal-Onset Seizures: An Observational, Prospective Study
por: Zhang, Ranran, et al.
Publicado: (2021)

The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond
por: Löscher, Wolfgang, et al.
Publicado: (2021)

Treatment with Cenobamate in Adult Patients with Lennox–Gastaut Syndrome: A Case Series
por: Falcicchio, Giovanni, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_40eegmpcieru8odcq6pmfsucu8